Researchers have, for the first time, successfully cultured skin cells from human tissue-proteins to produce skin grafts for safer treatment of severe burns. The new technique could potentially replace the decades-old method of culturing skin grafts from combined human and animal biological material — the latter is considered high-risk under pharmaceutical GMP standards and the resulting ‘xenografts’ are limited to the treatment of severe burns or for compassionate use.